Searchable abstracts of presentations at key conferences in endocrinology

ea0029p1225 | Obesity | ICEECE2012

Effect of secreted frizzled-related protein 2 (sFRP2) from adipose tissue on pancreatic cell function

Bujalska I. , Rabbitt E. , Gathercole L. , Stewart P.

The detrimental effect of excessive obesity on insulin resistance is well established. The expansion of adipose tissue is dependent on two processes: adipogenesis and angiogenesis and the Wnt signalling pathway has been reported to affect both. In adipose tissue the Wnt signalling pathway functions in a converse manner: increasing commitment of mesenchymal stem cells to preadipocytes and inhibiting differentiation of preadipocytes to mature adipocytes by decreasing expression ...

ea0005p141 | Endocrine Tumours and Neoplasia | BES2003

Abnormal expression of 11beta-hydroxysteroid dehydrogenase 2 in primary cultures of human pituitary adenomas

Rabbitt E , Bujalska I , Stewart P , Hewison M , Gittoes N

Glucocorticoids (GCs) mediate many of their physiological effects through inhibition of cell proliferation. More contentious is the antiproliferative action of GCs and their possible tumour-modifying effects in neoplastic tissues. However, in recent studies we have shown that 'prereceptor' metabolism of GCs by the enzyme 11beta-hydroxysteroid dehydrogenase (11beta-HSD) is a pivotal determinant of cell proliferation and tumour formation. Two isozymes of 11beta-HSD interconvert ...

ea0003oc36 | Hormone Action | BES2002

Increasing fracture risk with age: Possible role of local corticosteroid generation

Cooper M , Rabbitt E , Hewison M , Stewart P

The risk of bone fracture at most skeletal sites rises rapidly with age. Changes in bone mass account for only a small part of this increased risk - an additional factor is the progressive reduction in the ability to form new bone. This decrease in bone formation and increased fracture risk is reminiscent of changes seen with glucocorticoid excess, however, circulating corticosteroid levels do not change with age. We have proposed that local rather than circulating levels of c...

ea0019oc3 | Young Endocrinologist prize session | SFEBES2009

The role of gucocorticoid metabolism in osteosarcoma pathogenesis and treatment

Patel P , Hardy R , Gittoes N , Rabbitt E , Kindblom L , Stewart P , Cooper M

Osteosarcoma (OS) is an aggressive malignant tumour of osteoblasts occurring predominantly in children and young adults. Despite chemotherapy relapse is common and mortality remains ~50%. Non-transformed osteoblasts are highly sensitive to glucocorticoids which reduce proliferation and induce apoptosis. Previously, we observed that OS cells, but not normal osteoblasts, express 11beta-hydroxysteroid dehydrogenase type 2 (11β-HSD2). This enzyme powerfully inactivates cortis...

ea0003p146 | Endocrine Tumours and Neoplasia | BES2002

Inhibition of 11beta-HSD2 has an anti-proliferative effect on pituitary tumour cells

Rabbitt E , Bujalska I , Stewart P , Sheppard M , Hewison M , Gittoes N

The physiological effects of glucocorticoids (GCs) are, at least in part, mediated by an inhibition of cell proliferation. More contentious is their anti-proliferative action and possible tumour modifying effects in neoplastic tissues. Central to the action of GCs in target tissues is the expression and function of two isozymes of 11beta-hydroxysteroid dehydrogenase (11beta-HSD) that serve to interconvert active cortisol (F) and inactive cortisone (E). 11beta-HSD type 1 (11bet...

ea0019oc6 | Young Endocrinologist prize session | SFEBES2009

Locally generated glucocorticoids, rather than pro-inflammatory cytokines, directly regulate synovial DKK-1 expression in inflammatory arthritis

Hardy R , Ahasan M , Patel P , Filer A , Rabbitt E , Raza K , Stewart P , Buckley C , Cooper M

We have previously proposed a central role for locally generated glucocorticoids in the periarticular and systemic osteoporosis seen in rheumatoid arthritis (RA). Synovial fibroblasts (SFs) express the 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) enzyme and this expression increases dramatically with inflammation. Recently, production of DKK-1 (a Wnt signalling inhibitor known to inhibit bone formation) by SFs in response to inflammation has been proposed to ex...